|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1992-1-10
|
|
pubmed:abstractText |
The peripheral H1-inhibiting effects of cetirizine 10 mg and ebastine 10 mg were compared at the skin level after single oral administration. The study was performed in 9 healthy subjects under double-blind randomized crossover conditions. Both drugs were significantly effective up to 24 h. The suppressive effect of cetirizine was significantly more rapid and more marked.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0011-9075
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
183
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
208-11
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:1683840-Administration, Cutaneous,
pubmed-meshheading:1683840-Administration, Oral,
pubmed-meshheading:1683840-Adult,
pubmed-meshheading:1683840-Butyrophenones,
pubmed-meshheading:1683840-Capsules,
pubmed-meshheading:1683840-Cetirizine,
pubmed-meshheading:1683840-Double-Blind Method,
pubmed-meshheading:1683840-Female,
pubmed-meshheading:1683840-Histamine,
pubmed-meshheading:1683840-Histamine H1 Antagonists,
pubmed-meshheading:1683840-Humans,
pubmed-meshheading:1683840-Hydroxyzine,
pubmed-meshheading:1683840-Hypersensitivity,
pubmed-meshheading:1683840-Male,
pubmed-meshheading:1683840-Multivariate Analysis,
pubmed-meshheading:1683840-Piperidines,
pubmed-meshheading:1683840-Placebos,
pubmed-meshheading:1683840-Skin,
pubmed-meshheading:1683840-Skin Tests,
pubmed-meshheading:1683840-Time Factors
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Pharmacological modulation by cetirizine and ebastine of the cutaneous reactivity to histamine.
|
|
pubmed:affiliation |
Unité de Dermatologie professionnelle et de l'Environnement, UCL 3033, Bruxelles, Belgique.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
